comparemela.com

Latest Breaking News On - Sam riccitelli - Page 1 : comparemela.com

Biocept Inc sees poster at ASCO spotlight impressive performance of its CNSide assay compared to cytology in detecting a type of cancer

Biocept Inc (NASDAQ:BIOC) said that a poster presentation at the annual American Society of Clinical Oncology (ASCO) demonstrates the impressive ability of.

United statesSan diegoFeinberg schoolHaley appelPriya kumthekarSam riccitelliFeinberg school of medicineNorthwestern universityBaptist health south floridaBiocept incAmerican society of clinical oncologyMiami cancer instituteAmerican societyClinical oncologyBiocept chairman

Scientific Poster Presented at the 2023 ASCO Annual Meeting Highlights Performance of Biocept s CNSide™ Versus Cytology

Real-world retrospective study showed increased sensitivity for CNSide relative to standard cerebral spinal fluid cytology in detecting leptomeningeal metastases . | June 5, 2023

United statesFeinberg schoolSam riccitelliHaley appelPriya kumthekarAmerican society of clinical oncologyLaboratory developed testMiami cancer instituteNational comprehensive cancer networkBiocept incBaptist health south floridaFeinberg school of medicine at northwestern universityClinical oncologyAnnual meetingAssociate professorNorthwestern university

Enrollment Begins in FORESEE Clinical Trial Using Biocept s CNSide™ to Evaluate Patients with Leptomeningeal Metastases

Biocept, Inc. , a leading provider of molecular diagnostic assays, products and services, announces enrollment of the first patient in the FORESEE clinical trial with the Company’s proprietary. | March 24, 2023

Michael youssefSam riccitelliPriya kumthekarBiocept incLaboratory developed testFeinberg school of medicine at northwestern universityUt southwestern medical centerNational comprehensive cancer networkDepartment of hematologyDepartment of neurologyMedical centerAssistant professorAssociate professorFeinberg schoolNorthwestern universityPrincipal investigator

Biocept, Inc (NASDAQ:BIOC) Q3 2022 Earnings Call Transcript

Operator: Good day, and welcome to the Biocept Third Quarter Financial Results Conference Call. All participants are in a listen-only mode.

United statesStanford universitySan diegoSan franciscoJody cainSam riccitelliMichelle maliscoKemp dolliverQuyen daoBiocept cnsideLaura hupertPriya kumthekarSeema nagpalUniversity of californiaBiocept incCollege of american pathologists

Biocept to Host Key Opinion Leader Webinar on October 14 to Discuss its Proprietary CNSide™ Assay to Detect and Quantify Cancer that Metastasized to the Central Nervous System

Presenters include leading neuro-oncologists Dr. Priya U. Kumthekar of Northwestern University and Dr. Seema A. Nagpal of Stanford University . | October 6, 2022

United statesSam riccitelliSeemaa nagpalMichael duganPriyau kumthekarNational clinical trials networkBiocept incNortheastern ohio universityClinical associate professor at stanford universityAlliance for clinical trialsResident at northwestern universityNational cancerUniversity of pennsylvaniaUniversity of california san franciscoNorthwestern universityStanford university

vimarsana © 2020. All Rights Reserved.